C C
C C
Flekainid
Flekainid
Klass : C
Visa all info
Skriv ut
Kontakta oss
Doki K, Homma M, Kuga K, Kusano K, Watanabe S, Yamaguchi I et al. Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol. 2006;62:919-26.
Zordan R, Padrini R, Bernini V, Piovan D, Ferrari M. Influence of age and gender on the in vitro serum protein binding of flecainide. Pharmacol Res. 1993;28:259-64.
Doki K, Homma M, Kuga K, Aonuma K, Sakai S, Yamaguchi I et al. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol. 2007;63:951-7.
Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2018 [cited 2019-03-08.]
- Doki K, Homma M, Kuga K, Kusano K, Watanabe S, Yamaguchi I et al. Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol. 2006;62:919-26.
- Zordan R, Padrini R, Bernini V, Piovan D, Ferrari M. Influence of age and gender on the in vitro serum protein binding of flecainide. Pharmacol Res. 1993;28:259-64.
- Doki K, Homma M, Kuga K, Aonuma K, Sakai S, Yamaguchi I et al. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol. 2007;63:951-7.
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2018 [cited 2019-03-08.]